Compare ASPS & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPS | XTNT |
|---|---|---|
| Founded | 1999 | N/A |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.0M | 68.9M |
| IPO Year | 2025 | 2009 |
| Metric | ASPS | XTNT |
|---|---|---|
| Price | $7.00 | $0.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $1.00 |
| AVG Volume (30 Days) | 16.8K | ★ 182.2K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 112.00 | ★ 125.00 |
| EPS | ★ 0.15 | 0.03 |
| Revenue | ★ $942,213,000.00 | $53,337,000.00 |
| Revenue This Year | $9.17 | N/A |
| Revenue Next Year | $24.26 | $9.30 |
| P/E Ratio | $46.67 | ★ $16.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.74 | $0.39 |
| 52 Week High | $15.96 | $0.95 |
| Indicator | ASPS | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 46.16 |
| Support Level | $6.08 | $0.44 |
| Resistance Level | $7.33 | $0.68 |
| Average True Range (ATR) | 0.42 | 0.04 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 64.75 | 47.49 |
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.